State-of-the-art management of locally advanced head and neck cancer
TY Seiwert, EEW Cohen - British journal of cancer, 2005 - nature.com
During the past 20 years, treatments for head and neck squamous cell carcinoma (HNSCC)
have changed dramatically owing largely to the advent of novel approaches such as …
have changed dramatically owing largely to the advent of novel approaches such as …
The role of cetuximab in the treatment of squamous cell cancer of the head and neck
B Burtness - Expert opinion on biological therapy, 2005 - Taylor & Francis
The epidermal growth factor receptor (EGFR) is a member of the HER family of tyrosine
kinase growth factor receptors. Binding to EGFR by its natural ligands, mainly epidermal …
kinase growth factor receptors. Binding to EGFR by its natural ligands, mainly epidermal …
FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma
DL Schwartz, E Ford, J Rajendran, B Yueh… - International Journal of …, 2005 - Elsevier
PURPOSE: Image localization of head-and-neck squamous cell carcinoma lags behind
current techniques to deliver a precise radiation dose with intensity-modulated radiotherapy …
current techniques to deliver a precise radiation dose with intensity-modulated radiotherapy …
Tirapazamine, cisplatin, and radiation versus fluorouracil, cisplatin, and radiation in patients with locally advanced head and neck cancer: a randomized phase II trial …
Purpose To select one of two chemoradiotherapy regimens for locally advanced squamous
cell carcinoma (SCC) of the head and neck as the experimental arm for the next Trans …
cell carcinoma (SCC) of the head and neck as the experimental arm for the next Trans …
Concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: radiation therapy oncology group phase II trial 99-14
Purpose To investigate the feasibility of combining concomitant boost accelerated radiation
regimen (AFX-C) with cisplatin and to assess its toxicity and the relapse pattern and survival …
regimen (AFX-C) with cisplatin and to assess its toxicity and the relapse pattern and survival …
Supradose intra-arterial cisplatin and concurrent radiation therapy for the treatment of stage IV head and neck squamous cell carcinoma is feasible and efficacious in a …
KT Robbins, P Kumar, J Harris, T McCulloch… - Journal of clinical …, 2005 - ascopubs.org
Purpose To determine the feasibility of high-dose intra-arterial (IA) cisplatin and concurrent
radiation therapy (RT) for head and neck squamous cell carcinoma in the multi-institutional …
radiation therapy (RT) for head and neck squamous cell carcinoma in the multi-institutional …
Pretreatment anemia is correlated with the reduced effectiveness of radiation and concurrent chemotherapy in advanced head and neck cancer
RG Prosnitz, B Yao, CL Farrell, R Clough… - International Journal of …, 2005 - Elsevier
PURPOSE: Pretreatment anemia is an adverse prognostic variable in squamous cell head-
and-neck cancer (HNC) patients treated with radiotherapy (RT) alone. Tumor hypoxia is an …
and-neck cancer (HNC) patients treated with radiotherapy (RT) alone. Tumor hypoxia is an …
Hyperfractionated accelerated radiotherapy in combination with weekly cisplatin for locally advanced head and neck cancer
GK Beckmann, F Hoppe, L Pfreundner… - Head & neck, 2005 - Wiley Online Library
Background. The purpose of this study was to determine the feasibility and efficacy of
hyperfractionated accelerated radiotherapy (HFRCB) combined with simultaneous …
hyperfractionated accelerated radiotherapy (HFRCB) combined with simultaneous …
Metabolic abnormalities associated with weight loss during chemoirradiation of head-and-neck cancer
Purpose: Weight loss caused by acute mucositis and dysphagia is common during
concurrent chemoirradiation (chemo-RT) of head-and-neck (HN) cancer. The metabolic …
concurrent chemoirradiation (chemo-RT) of head-and-neck (HN) cancer. The metabolic …
Management of paranasal sinus malignancy
TA Day, RA Beas, RJ Schlosser, BA Woodworth… - … treatment options in …, 2005 - Springer
Opinion statement Malignancies of the nasal cavity and paranasal sinuses represent a wide
spectrum of histologies, tissues of origin, and anatomic primary sites. The inherent difficulty …
spectrum of histologies, tissues of origin, and anatomic primary sites. The inherent difficulty …